182 related articles for article (PubMed ID: 38317799)
41. A cohesive European policy for hepatitis B vaccination, are we there yet?
Lernout T; Hendrickx G; Vorsters A; Mosina L; Emiroglu N; Van Damme P
Clin Microbiol Infect; 2014 May; 20 Suppl 5():19-24. PubMed ID: 24829936
[TBL] [Abstract][Full Text] [Related]
42. Suitable hepatitis B vaccine for adult immunization in China: a systematic review and meta-analysis.
Wu Z; Bao H; Yao J; Chen Y; Lu S; Li J; Jiang ZG; Ren JJ; Xu KJ; Ruan B; Yang SG; Xie TS; Hu Y
Hum Vaccin Immunother; 2019; 15(1):220-227. PubMed ID: 30089437
[TBL] [Abstract][Full Text] [Related]
43. Strengthening vaccination policies in Latin America: an evidence-based approach.
Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
[TBL] [Abstract][Full Text] [Related]
44. Prevention and control of hepatitis B in China.
Sun Z; Ming L; Zhu X; Lu J
J Med Virol; 2002 Jul; 67(3):447-50. PubMed ID: 12116043
[TBL] [Abstract][Full Text] [Related]
45. Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China.
Miao N; Zheng H; Sun X; Zhang G; Wang F
Sci Rep; 2020 Oct; 10(1):18155. PubMed ID: 33097788
[TBL] [Abstract][Full Text] [Related]
46. Global progress toward universal childhood hepatitis B vaccination, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(36):868-70. PubMed ID: 12970620
[TBL] [Abstract][Full Text] [Related]
47. Strategies implemented to address vaccine hesitancy in France: A review article.
Fokoun C
Hum Vaccin Immunother; 2018 Jul; 14(7):1580-1590. PubMed ID: 29608390
[TBL] [Abstract][Full Text] [Related]
48. Factors associated with recommendation behaviors of four non-National Immunization Program vaccines: a cross-sectional survey among public health workers in China.
Lyu Y; Lai X; Ma Y; Fang H
Infect Dis Poverty; 2023 Oct; 12(1):91. PubMed ID: 37805654
[TBL] [Abstract][Full Text] [Related]
49. [Seroepidemiological analysis of hepatitis B virus infection among adolescents aged 0-14 years in Henan Province and preliminary evaluation of the effectiveness of childhood hepatitis B vaccine immunization program].
Guo YH; Chen YP; Dou QH; Liu Q; Yang JH; Seng MH; Lyu YY; Wang CS; Lu MX; Xu J; Zhang YY; Zhao DY
Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Feb; 58(2):202-207. PubMed ID: 38387951
[No Abstract] [Full Text] [Related]
50. Loss of confidence in vaccines following media reports of infant deaths after hepatitis B vaccination in China.
Yu W; Liu D; Zheng J; Liu Y; An Z; Rodewald L; Zhang G; Su Q; Li K; Xu D; Wang F; Yuan P; Xia W; Ning G; Zheng H; Chu Y; Cui J; Duan M; Hao L; Zhou Y; Wu Z; Zhang X; Cui F; Li L; Wang H
Int J Epidemiol; 2016 Apr; 45(2):441-9. PubMed ID: 27174834
[TBL] [Abstract][Full Text] [Related]
51. [Hepatitis B vaccination: knowledge and acceptance by Swiss physicians].
Gugelmann RJ; Freed GL; Desgrandchamps D; Diebold P
Soz Praventivmed; 1998; 43 Suppl 1():S57-60, S130-3. PubMed ID: 9833268
[TBL] [Abstract][Full Text] [Related]
52. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
Menzies R; Turnour C; Chiu C; McIntyre P
Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
[TBL] [Abstract][Full Text] [Related]
53. [Recognition of the vaccination: a key and important strategy in controlling vaccine preventable diseases].
Zhou L; Cui FQ; Pan Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):755-758. PubMed ID: 27655592
[TBL] [Abstract][Full Text] [Related]
54. COVID-19 vaccine hesitancy - reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic.
Dhama K; Sharun K; Tiwari R; Dhawan M; Emran TB; Rabaan AA; Alhumaid S
Hum Vaccin Immunother; 2021 Oct; 17(10):3495-3499. PubMed ID: 34191680
[TBL] [Abstract][Full Text] [Related]
55. Caregivers' perceptions on routine childhood vaccination: A qualitative study on vaccine hesitancy in a South Brazil state capital.
de Souza Amorim Matos CC; Couto MT; Oduwole EO; Shey Wiysonge C
Hum Vaccin Immunother; 2024 Dec; 20(1):2298562. PubMed ID: 38196242
[TBL] [Abstract][Full Text] [Related]
56. The landscape of vaccines in China: history, classification, supply, and price.
Zheng Y; Rodewald L; Yang J; Qin Y; Pang M; Feng L; Yu H
BMC Infect Dis; 2018 Oct; 18(1):502. PubMed ID: 30286735
[TBL] [Abstract][Full Text] [Related]
57. Hepatitis B vaccine birth dose in India: time to reconsider.
Parija PP; M MK
Hum Vaccin Immunother; 2020; 16(1):158-160. PubMed ID: 31295047
[TBL] [Abstract][Full Text] [Related]
58. Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1 and 29years from 2006 to 2014.
Zhou Y; He H; Deng X; Yan R; Tang X; Xie S; Yao J
Vaccine; 2017 Aug; 35(34):4355-4361. PubMed ID: 28687404
[TBL] [Abstract][Full Text] [Related]
59. Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules.
Miller MA; McCann L
Health Econ; 2000 Jan; 9(1):19-35. PubMed ID: 10694757
[TBL] [Abstract][Full Text] [Related]
60. Occurrence and Reduction of Hepatitis B Vaccine Hesitancy Among Medical University Students - Shanxi Province, China, 2020.
Kong H; Cui X; Zhang Y; Xue Q; Shi J; Yao T; Guo Y; Xu X; Wang S; Feng Y
China CDC Wkly; 2024 May; 6(19):431-436. PubMed ID: 38854750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
